ASML Boosts 2026 Outlook Again as AI Chip Boom Drives Record Orders
Q2 revenue and profit beat expectations.
Already have an account? Sign in.
Q2 revenue and profit beat expectations.
Xos secures its first U.S. Air Force contract to build a military-grade Xos Hub mobile charging system, marking its entry into defense.
Topline data from Amylyx’s Phase 3 LUCIDITY trial of avexitide for PBH arrives August 18. Prior results and unmet need fuel optimism.
4D Molecular gains support as B. Riley views EyePoint’s Phase 3 setback as favorable for its lead gene therapy candidate 4D-150.